EPB41L4A-AS1 and UNC5B-AS1 Have Diagnostic and Prognostic Significance in Osteosarcoma

Overview

Journal J Orthop Surg Res

Publisher Biomed Central

Specialty Orthopedics

Date 2023 Mar 30

PMID 36998043

Authors

Ying Yan

Xiaochuan Liu

Yamei Li

Jingyi Yan

Ping Zhao

Lu Yang

Affiliations

Soon will be listed here.

Abstract

Background: Deregulation of lncRNAs has been observed in human osteosarcoma. This study explored the diagnostic and prognostic significance of EPB41L4A-AS1 and UNC5B-AS1 in osteosarcoma.

Methods: Relative levels of EPB41L4A-AS1 and UNC5B-AS1 were detected in osteosarcoma tissue samples and cells. The ability to distinguish osteosarcoma from health was assessed by receiver operating characteristic (ROC) curve construction. Kaplan-Meier (K-M) and Cox proportional-hazards analyses were performed for prognosis factors. The bioinformatics approach was used to identify targeting miRNA for EPB41L4A-AS1 and UNC5B-AS1. Kaplan-Meier survival curves and Whitney Mann U tests were conducted for validating the statistical significance. In cell culture experiments, the influence of EPB41L4A-AS1 and UNC5B-AS1 on proliferation, migration, and invasion of the osteosarcoma cell line was examined by CCK-8 and Transwell assays.

Results: Levels of EPB41L4A-AS1 and UNC5B-AS1 were upregulated in osteosarcoma patients and cells compared with the healthy participants and normal cell lines. EPB41L4A-AS1 and UNC5B-AS1 have a potent ability to distinguish the patients with osteosarcoma from the health. EPB41L4A-AS1 and UNC5B-AS1 levels correlated with SSS stage. Patients with high levels of EPB41L4A-AS1 and UNC5B-AS1 had significantly shorter survival times. EPB41L4A-AS1 and UNC5B-AS1 were independent prognostic indexes for overall survival. miR-1306-5p was a common target for EPB41L4A-AS1 and UNC5B-AS1. A propulsive impact on cell proliferation, migration, and invasion by EPB41L4A-AS1 and UNC5B-AS1 was observed, but can be rescued by miR-1306-5p.

Conclusions: It was concluded that upregulations of EPB41L4A-AS1 and UNC5B-AS1 expression were diagnostic and prognostic biomarkers for human osteosarcoma. EPB41L4A-AS1 and UNC5B-AS1 contribute to the biological behavior of osteosarcoma via miR-1306-5p.

Citing Articles

Long Non-Coding RNA EPB41L4A-AS1 Serves as a Diagnostic Marker for Chronic Periodontitis and Regulates Periodontal Ligament Injury and Osteogenic Differentiation by Targeting miR-214-3p/YAP1.

Li R, Huang Z, Chen M J Inflamm Res. 2025; 18:2483-2497.

PMID: 39991662 PMC: 11847424. DOI: 10.2147/JIR.S491724.

regulates cervical cancer by proliferative cells: mendelian randomization and single-cell transcriptomics analyses.

Wang Y, Yao J, Wei M, Jiang Q, Luo H, Lai S Transl Cancer Res. 2025; 14(1):354-370.

PMID: 39974380 PMC: 11833381. DOI: 10.21037/tcr-24-949.

Comprehensive analysis of ESCRT transcriptome-associated signatures and identification of the regulatory role of LMO7-AS1 in osteosarcoma.

Zhao S, Tian D, Huang F, Wang L, Cheng J, He Z Cancer Cell Int. 2025; 25(1):29.

PMID: 39885569 PMC: 11783933. DOI: 10.1186/s12935-025-03659-4.

Diagnostic value of combined detection of AKP, TSGF, and LDH for pediatric osteosarcoma: a case-control study.

Sun T, Ma J, Zhu S, Wang K Am J Transl Res. 2024; 16(8):3667-3677.

PMID: 39262698 PMC: 11384345. DOI: 10.62347/IGEA4076.

EPB41L4A-AS1 is required to maintain basal autophagy to modulates Aβ clearance.

Wang Z, Wang R, Niu L, Zhou X, Han J, Li K NPJ Aging. 2024; 10(1):24.

PMID: 38704365 PMC: 11069514. DOI: 10.1038/s41514-024-00152-6.

References

Sun H, Peng G, Wu H, Liu M, Mao G, Ning X . Long non-coding RNA MEG3 is involved in osteogenic differentiation and bone diseases (Review). Biomed Rep. 2020; 13(1):15-21. PMC: 7257936. DOI: 10.3892/br.2020.1305. View

Dykes I, Emanueli C . Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA. Genomics Proteomics Bioinformatics. 2017; 15(3):177-186. PMC: 5487525. DOI: 10.1016/j.gpb.2016.12.005. View

Song K, Song J, Lin K, Chen F, Ma X, Jiang J . Survival analysis of patients with metastatic osteosarcoma: a Surveillance, Epidemiology, and End Results population-based study. Int Orthop. 2019; 43(8):1983-1991. DOI: 10.1007/s00264-019-04348-4. View

Szikszai K, Krejcik Z, Klema J, Loudova N, Hrustincova A, Belickova M . LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome. Cancers (Basel). 2020; 12(10). PMC: 7598221. DOI: 10.3390/cancers12102726. View

Bin J, Nie S, Tang Z, Kang A, Fu Z, Hu Y . Long noncoding RNA EPB41L4A-AS1 functions as an oncogene by regulating the Rho/ROCK pathway in colorectal cancer. J Cell Physiol. 2020; 236(1):523-535. DOI: 10.1002/jcp.29880. View

Sadykova L, Ntekim A, Muyangwa-Semenova M, Rutland C, Jeyapalan J, Blatt N . Epidemiology and Risk Factors of Osteosarcoma. Cancer Invest. 2020; 38(5):259-269. DOI: 10.1080/07357907.2020.1768401. View

Fu J, Zhang Y, Wang M, Hu J, Fang Y . Inhibition of the long non-coding RNA UNC5B-AS1/miR-4455/RSPO4 axis reduces cervical cancer growth in vitro and in vivo. J Gene Med. 2021; 23(12):e3382. DOI: 10.1002/jgm.3382. View

Huang X, Pan J, Wang G, Huang T, Li C, Wang Y . UNC5B-AS1 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells via regulating miR-4306/KDM2A axis. Cell Cycle. 2021; 20(20):2114-2124. PMC: 8565830. DOI: 10.1080/15384101.2021.1962632. View

Yang F, Lv S . LncRNA EPB41L4A-AS1 Regulates Cell Proliferation, Apoptosis and Metastasis in Breast Cancer. Ann Clin Lab Sci. 2022; 52(1):3-11. View

10.

Smeland S, Bielack S, Whelan J, Bernstein M, Hogendoorn P, Krailo M . Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. 2019; 109:36-50. PMC: 6506906. DOI: 10.1016/j.ejca.2018.11.027. View

11.

Hong-Bin S, Wan-Jun Y, Chen-Hui D, Xiao-Jie Y, Shen-Song L, Peng Z . Identification of an Iron Metabolism-Related lncRNA Signature for Predicting Osteosarcoma Survival and Immune Landscape. Front Genet. 2022; 13:816460. PMC: 8961878. DOI: 10.3389/fgene.2022.816460. View

12.

Cui P, Zhao X, Liu J, Chen X, Gao Y, Tao K . miR-146a interacting with lncRNA EPB41L4A-AS1 and lncRNA SNHG7 inhibits proliferation of bone marrow-derived mesenchymal stem cells. J Cell Physiol. 2019; 235(4):3292-3308. DOI: 10.1002/jcp.29217. View

13.

Aurilia C, Donati S, Palmini G, Miglietta F, Iantomasi T, Brandi M . The Involvement of Long Non-Coding RNAs in Bone. Int J Mol Sci. 2021; 22(8). PMC: 8069547. DOI: 10.3390/ijms22083909. View

14.

Pin F, Prideaux M, Bonewald L, Bonetto A . Osteocytes and Cancer. Curr Osteoporos Rep. 2021; 19(6):616-625. PMC: 8963429. DOI: 10.1007/s11914-021-00712-9. View

15.

Wang Y, Bhandari A, Niu J, Yang F, Xia E, Yao Z . The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines. Hum Cell. 2019; 32(3):334-342. DOI: 10.1007/s13577-019-00242-8. View

16.

Eaton B, Schwarz R, Vatner R, Yeh B, Claude L, Indelicato D . Osteosarcoma. Pediatr Blood Cancer. 2020; 68 Suppl 2:e28352. DOI: 10.1002/pbc.28352. View

17.

Schmitz S, Grote P, Herrmann B . Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016; 73(13):2491-509. PMC: 4894931. DOI: 10.1007/s00018-016-2174-5. View

18.

Diederichs S, Bartsch L, Berkmann J, Frose K, Heitmann J, Hoppe C . The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations. EMBO Mol Med. 2016; 8(5):442-57. PMC: 5126213. DOI: 10.15252/emmm.201506055. View

19.

Yang G, Wu Y, Wan R, Sang H, Liu H, Huang W . The role of non‑coding RNAs in the regulation, diagnosis, prognosis and treatment of osteosarcoma (Review). Int J Oncol. 2021; 59(3). DOI: 10.3892/ijo.2021.5249. View

20.

Tan J, Long S, Zhang T . [Effects of LncRNA UNC5B-AS1 on adhesion, invasion and migration of lung cancer cells and its mechanism]. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2021; 36(6):622-627. DOI: 10.12047/j.cjap.5993.2020.130. View